301267 华厦眼科
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)4.8447.48712.36414.78927.983
总资产报酬率 ROA (%)3.5045.6029.43610.32216.905
投入资产回报率 ROIC (%)4.0586.36310.51311.74321.913

边际利润分析
销售毛利率 (%)45.20044.19349.03248.04846.038
营业利润率 (%)19.25016.00324.25522.49921.268
息税前利润/营业总收入 (%)19.09614.85621.78621.19620.317
净利润/营业总收入 (%)14.04110.63416.88015.74914.803

收益指标分析
经营活动净收益/利润总额(%)99.376101.769101.713106.303105.316
价值变动净收益/利润总额(%)6.95511.67710.2372.2191.500
营业外收支净额/利润总额(%)-6.394-14.433-13.939-11.296-11.917

偿债能力分析
流动比率 (X)3.9244.6494.8755.8471.705
速动比率 (X)3.7494.4934.6685.6481.545
资产负债率 (%)25.77323.98522.51323.84142.583
带息债务/全部投入资本 (%)3.8853.7303.9863.4838.100
股东权益/带息债务 (%)2,158.4062,243.9822,166.1872,400.087859.554
股东权益/负债合计 (%)277.755304.875340.438318.601133.609
利息保障倍数 (X)19.03917.06143.69921.62115.462

营运能力分析
应收账款周转天数 (天)26.27927.22223.25121.33220.037
存货周转天数 (天)29.09029.47632.05730.32525.311